Diastolic heart function in RA patients.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 17957370)

Published in Rheumatol Int on October 24, 2007

Authors

M Wislowska1, B Jaszczyk, M Kochmański, S Sypuła, M Sztechman

Author Affiliations

1: Department of Rheumatology, Central Clinical Hospital, Wołoska 137, 02-507 Warsaw, Poland. mwislowska@wp.pl

Articles cited by this

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol (1986) 18.40

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67

Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc (1949) 4.18

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09

Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol (1999) 3.02

The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74

The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two cases. Ann Intern Med (1963) 2.20

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol (2003) 2.07

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest (1994) 2.01

Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med (2000) 2.00

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med (1993) 1.68

Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63

Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis. N Engl J Med (1962) 1.51

Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol (2004) 1.37

Diastolic function abnormalities in rheumatoid arthritis. Evaluation By echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis (2000) 1.21

Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis (1989) 1.14

Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther (2005) 1.13

Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation (2000) 1.10

Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest (1996) 1.08

Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol (2003) 1.03

Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum (2004) 1.02

Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum (2001) 1.00

Impaired diastolic function in active rheumatoid arthritis. Relationship with disease duration. Clin Exp Rheumatol (1999) 0.98

Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol (1998) 0.97

CARDIAC INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ALLIED DISORDERS: CURRENT CONCEPTS. Mod Concepts Cardiovasc Dis (1964) 0.97

Low diastolic pressure as a clinical feature of rheumatoid arthritis and its possible etiologic significance. Am J Med Sci (1954) 0.92

Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest (1993) 0.92

Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study. Rheumatol Int (2003) 0.92

Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling. Am J Cardiol (1998) 0.80

Diastolic heart failure. BMJ (2003) 0.79

Diastolic heart failure: the forgotten manifestation of hypertensive heart disease. Curr Hypertens Rep (2004) 0.75

Articles by these authors

Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol (1998) 0.97

Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int (1999) 0.93

Systolic and diastolic heart function in SLE patients. Rheumatol Int (2009) 0.81

Hemorrheological indices, catecholamines, neuropeptide Y and serotonin in patients with essential hypertension. Blood Press (1997) 0.76

[Effect of verapamil on blood viscosity in ischemic heart disease]. Pol Arch Med Wewn (1987) 0.75

[Rare case of asystolic cardiac arrest after administration of xylocaine]. Kardiol Pol (1981) 0.75

[Effect of the treatment of chronic circulatory insufficiency on the rheologic parameters of the blood]. Pol Tyg Lek (1986) 0.75

[The effect of serum potassium level at the time of hospitalization on the development of ventricular arrhythmias in the acute phase of myocardial infarction]. Pol Tyg Lek (1988) 0.75

[Vasodilator agents in the treatment of acute myocardial infarction]. Pol Tyg Lek (1988) 0.75

[Evaluation of blood rheology indices in patients with pheochromocytoma]. Pol Arch Med Wewn (1996) 0.75

[Prognostic significance of primary ventricular fibrillation in the hospital phase of acute myocardial infarction]. Pol Tyg Lek (1988) 0.75

[Effectiveness of fendiline in ischemic heart disease]. Pol Tyg Lek (1988) 0.75

[Effect of drugs (dipyridamole, heparin, propranolol, and verapamil) on blood viscosity and plasticity of erythrocytes in in vitro studies]. Pol Tyg Lek (1982) 0.75

[Thrombi of the left ventricle, infarction location and method of treatment]. Wiad Lek (1990) 0.75

[Changes in plasma viscosity and in various blood coagulation indicators in acute myocardial infarct]. Kardiol Pol (1980) 0.75

[The effect of streptokinase treatment on the course and extent of myocardial infarction]. Wiad Lek (1990) 0.75

[Indicators of blood viscosity in women during menopause]. Pol Arch Med Wewn (1987) 0.75

[Blood digoxin level in outpatients]. Pol Tyg Lek (1980) 0.75

[Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease]. Wiad Lek (1993) 0.75

[Effect of physical exertion on the transvalvular pressure gradient measured by Doppler echocardiography in patients with implanted mitral valve prosthesis]. Kardiol Pol (1988) 0.75

[Remote results of the treatment of patients with various types of mitral valve prosthesis]. Kardiol Pol (1988) 0.75

Myocarditis complicated by cardiopulmonary shock, treated with extracorporeal assist device and heart transplantation. Transplant Proc (2002) 0.75